Top Markets
#1 Black Phoenix Black Phoenix +355.27%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +62.66%
#4 OpenEden OpenEden +56.84%
#5 Akedo Akedo +56.63%
#6 BasedHype BasedHype +27.37%
#7 Cryptopia Cryptopia +21.54%
#8 Avantis Avantis +20.66%
#9 Humanity Humanity +17.61%
#10 Ether.fi Ether.fi +17.54%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Cyxone AB (publ) Cyxone AB (publ)

Cyxone AB (publ)

CYXO
Rank in Stocks #40403
Cyxone AB (publ) is a clinical-stage biotechnology firm focused on developing... Cyxone AB (publ) is a clinical-stage biotechnology firm focused on developing innovative, disease-modifying therapies. Its primary therapeutic targets include rheumatoid arthritis, multiple sclerosis, and acute respiratory illnesses caused by viruses. The company's pipeline features Rabeximod, currently in Phase II clinical trials for both rheumatoid arthritis and COVID-19. Additionally, T20K, a drug candidate for multiple sclerosis, is undergoing Phase 1 evaluation. Established in 2015, the company is headquartered in Malmö, Sweden.
Share Price
$0.00162013
Last synced: 2025-01-03
Market Cap
$156.25K
Change (1 day)
0.36%
Change (1 year)
0.00%
Country
SE
Trade Cyxone AB (publ) (CYXO)

Category

Healthcare
Number of shares outstanding for Cyxone AB (publ) (CYXO)
Number of shares outstanding as of June 2024: 236.74M
According to Cyxone AB (publ) latest financial reports and stock price the company's current number of shares outstanding is 236.74M. At the end of December 2022 the company had 95.77M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Cyxone AB (publ) (CYXO) from 2015 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 236.74M 126.55%
2023 104.50M 9.11%
2022 95.77M 55.94%
2021 61.42M -0.61%
2020 61.79M 38.53%
2019 44.61M 15.51%
2018 38.61M 92.92%
2017 20.02M 25.22%
2016 15.98M 9.97%
2015 14.54M 0.00%
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 7.25%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -73.73%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -100.00%
BE